E-resources
PDF-
Olson, Samantha M; Newhams, Margaret M; Halasa, Natasha B; Price, Ashley M; Boom, Julie A; Sahni, Leila C; Pannaraj, Pia S; Irby, Katherine; Walker, Tracie C; Schwartz, Stephanie P; Maddux, Aline B; Mack, Elizabeth H; Bradford, Tamara T; Schuster, Jennifer E; Nofziger, Ryan A; Cameron, Melissa A; Chiotos, Kathleen; Cullimore, Melissa L; Gertz, Shira J; Levy, Emily R; Kong, Michele; Cvijanovich, Natalie Z; Staat, Mary A; Kamidani, Satoshi; Chatani, Brandon M; Bhumbra, Samina S; Bline, Katherine E; Gaspers, Mary G; Hobbs, Charlotte V; Heidemann, Sabrina M; Maamari, Mia; Flori, Heidi R; Hume, Janet R; Zinter, Matt S; Michelson, Kelly N; Zambrano, Laura D; Campbell, Angela P; Patel, Manish M; Randolph, Adrienne G
The New England journal of medicine, 02/2022, Volume: 386, Issue: 8Journal Article
Investigators used a case–control, test-negative design to assess the effectiveness of the BNT162b2 vaccine in adolescents for the prevention of Covid-19–related hospitalization, ICU admission, or receipt of life support. Among 445 case patients and 777 controls, of the 180 patients admitted to an ICU, only 2 had been fully vaccinated; all 7 deaths occurred in unvaccinated patients.
